In the last 20 years many studies, including meta-analyses, with more than 8,000 patients considered have been published analyzing the prognostic and predictive role of KRAS mutations in NSCLC The majority of these results indicated KRAS as a negative prognostic and predictive marker [7-11, 17]. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.